We are live on ! Find out more
RNTX

Rein Therapeutics
RNTX

43 hedge funds and large institutions have $18.9M invested in Rein Therapeutics in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

0.04% more ownership

Funds ownership: 1.82% → 1.85% (+0.04%)

0% more funds holding

Funds holding: 43 → 43 (0)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

44% less capital invested

Capital invested by funds: $33.6M → $18.9M (-$14.7M)

Holders
43
Holders Change
–
Holders Change %
0%
% of All Funds
0.66%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
11
Reduced
9
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$502K
2
William Blair & Company
William Blair & Company
Illinois
+$204K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$65.9K
4
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$63.9K
5
Jane Street
Jane Street
New York
+$33K

Top Sellers

Rank Fund Capital Flow
1
AIIC
AJU IB Investment Company
South Korea
-$528K
2
Renaissance Technologies
Renaissance Technologies
New York
-$204K
3
VF
Virtu Financial
New York
-$185K
4
GW
GW & Wade
Massachusetts
-$103K
5
ECM
ExodusPoint Capital Management
New York
-$31K
Name Holding Trade Value Shares
Change 		Change in
Stake
KAS
26
Kestra Advisory Services
Texas
$17K – – –
US Bancorp
27
US Bancorp
Minnesota
$14K – – –
UBS Group
28
UBS Group
Switzerland
$13K +$12.1K +784 +204%
Mercer Global Advisors
29
Mercer Global Advisors
Colorado
$12K +$851 +55 +5%
LSAG
30
Lake Street Advisors Group
New Hampshire
$10K – – –
Cetera Investment Advisers
31
Cetera Investment Advisers
Illinois
$10K +$14.2K +917 New
HighTower Advisors
32
HighTower Advisors
Illinois
$7K +$9.28K +600 New
Commonwealth Equity Services
33
Commonwealth Equity Services
Massachusetts
$6K -$155 -10 -2%
KPW
34
Kore Private Wealth
New York
$6K – – –
RWP
35
Ridgecrest Wealth Partners
California
$6K – – –
LPL Financial
36
LPL Financial
California
$6K +$7.73K +500 New
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$6K +$7.78K +503 New
Two Sigma Advisers
38
Two Sigma Advisers
New York
$6K +$8.74K +565 New
HF
39
HRT Financial
New York
$5K -$6.7K -433 -45%
Bank of America
40
Bank of America
North Carolina
$4K -$2.64K -171 -30%
TRCT
41
Tower Research Capital (TRC)
New York
$1K +$820 +53 New
SWM
42
Spire Wealth Management
Virginia
$1K +$1.73K +112 New
AIIC
43
AJU IB Investment Company
South Korea
– -$528K -25,878 Closed
VF
44
Virtu Financial
New York
– -$185K -9,047 Closed
GW
45
GW & Wade
Massachusetts
– -$103K -5,050 Closed
PCS
46
Personal CFO Solutions
New Jersey
– -$31K -1,525 Closed
ECM
47
ExodusPoint Capital Management
New York
– -$31K -1,505 Closed
Barclays
48
Barclays
United Kingdom
– -$26K -1,264 Closed
Qube Research & Technologies (QRT)
49
Qube Research & Technologies (QRT)
United Kingdom
– -$26K -1,264 Closed
MIH
50
Meitav Investment House
Israel
– -$21K -1,050 Closed
1
2
3

RNTX Hedge Fund Activity: Q4 2021 in Review

43 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Rein Therapeutics (RNTX) for Q4 2021, worth a combined $18.9M — down 44% from $33.6M a quarter earlier.

Fund positioning in RNTX was balanced in Q4 2021: 10 funds opened new positions, 10 closed out, 11 added to existing stakes and 9 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $502K. The largest seller was AJU IB Investment Company, exiting entirely with an estimated $528K sold.

  • 43 institutional investors held Rein Therapeutics (RNTX) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $18.9M of Rein Therapeutics stock for Q4 2021, down 44% quarter-over-quarter.
  • 10 funds opened new Rein Therapeutics positions in Q4 2021 and 10 closed out, a net change of 0 holders.
  • The largest Rein Therapeutics buyer in Q4 2021 was Morgan Stanley, an estimated $502K added.
  • The largest Rein Therapeutics seller in Q4 2021 was AJU IB Investment Company, an estimated $528K sold.

Based on aggregated 13F filings for Q4 2021.